Tuesday, July 30 7:00 a.m. – 8:30 a.m. Location: Hyatt Regency McCormick Place Room: Regency Ballroom C-E Sponsored by Abbott
High sensitivity (hs) cardiac troponin assays have revolutionized the care of patients with suspected myocardial infarction, allowing for faster triage and more accurate diagnostic protocols. However, interpretation of cardiac troponin results requires consideration of patient and assay specific factors. This expert led session will cover analytical and clinical aspects across high and low hs-cardiac troponin results, while covering factors that may lead to potential misdiagnosis of myocardial infarction.
Gillian Murtagh, MD, MBA Director of Systems, Cardiology / Pulmonology Medical and Scientific Affairs Core Diagnostics
Fred S. Apple PhD, DABCC Medical Director Clinical & Forensic Toxicology, Laboratory Medicine & Pathology, Hennepin Healthcare/Hennepin County Medical Center Principal Investigator, Cardiac Biomarkers Trials Laboratory & Hennepin Healthcare Research Institute Professor, Laboratory Medicine & Pathology, University of Minnesota
Christopher W. Farnsworth, PhD, DABCC, FADLM Associate Professor, Pathology & Immunology Section Head, Clinical Chemistry Co-Director, Clinical Chemistry Fellowship Washington University in St. Louis
Be the first to get all the latest news.